-5%
Highnoon Labs
Genthro 500mg Tablets 6s
20 Tablets
Rated 4.5 out of 5 (49)
Rs. 1,275Rs. 1,340
In Stock
-5%
GSK
Apixaban 2 5mg Tab 30s
Rated 4.5 out of 5 (30)SKU HP-00981
A tablet containing Apixaban, indicated for Stroke.
Rs. 2,155Rs. 2,270-5%
You save Rs. 115
60 Capsules
In StockSet your city for an exact delivery date
In stock at selected branches
Quantity
Apixaban 2 5mg Tab 30s quantity: 1
- 100% authentic
- Free over Rs. 1,500
- Pharmacist verified
- 7-day returns
Total for 1 pack: Rs. 2,155
What it is used for: Stroke.
Indications as listed by the manufacturer: Apixaban is indicated for: • The prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective knee or hip replacement surgery. • The prevention of stroke and systemic embolism in patients with atrial fibrillation. • The treatment of venous thromboembolic events (deep vein thrombosis [DVT], pulmonary embolism [PE]) and prevention of recurrent DVT and PE.
Active ingredient: Apixaban.
Reported side effects: Common: Haemorrhage, haematoma, epistaxis, gastrointestinal haemorrhage, rectal haemorrhage, gingival bleeding, haematuria and contusion. Uncommon: Pruritus, eye haemorrhage (including conjunctival haemorrhage), haemoptysis, haematochezia, abnormal vaginal haemorrhage, urogenital haemorrhage, occult blood positive, traumatic haemorrhage, post procedural haemorrhage and incision site haemorrhage. Rare: Brain haemorrhage and respiratory tract haemorrhage .
Known drug interactions: Inhibitors of CYP3A4 and P-gp , g. Inducers of CYP3A4 and P-gp (e.g., rifampin, carbamazepine, phenytoin, St. John’s wort) , thrombolytic agents, fibrinolytics, GPIIb/IIIa receptor antagonists, thienopyridines (e.g., clopidogrel), dipyridamole, dextran, heparin, aspirin, chronic NSAID and sulfinpyrazone.
- Sourced through authorised distributors and checked against batch and expiry on arrival
- Dispensed by a registered pharmacist from our DRAP-licensed branches
- Prescription verified by a pharmacist before your order is dispatched
- Same-day delivery in Karachi, Lahore and Islamabad on orders placed before 6pm
Prevention of stroke and systemic embolism in patients with atrial fibrillation : The recommended dose of Apixaban for most patients is 5mg taken orally twice daily. The recommended dose of Apixaban is 2.5mg twice daily in patients with at least two of the following characteristics: • age greater than or equal to 80 years • body weight less than or equal to 60 kg • serum creatinine greater than or equal to 1.5mg/dL . Prevention of venous thromboembolic events (VTE) following Hip or Knee Replacement Surgery : The recommended dose of Apixaban is 2.5mg taken orally twice daily . Treatment of DVT and PE and Prevention of recurrent DVT and PE : The recommended dose of Apixaban is 10mg taken orally twice daily for 7 days, followed by 5mg taken orally twice daily for the treatment of acute DVT or PE . OR As directed by your physician .
Active ingredient: Apixaban. Labelled strength: 2.5mg.
- Apixaban is contraindicated in: • Hypersensitivity to the active substance or to any of the excipient of the product. • Active clinically significant bleeding including GI bleeding. • Hepatic disease associated with coagulopathy and clinically relevant bleeding risk. • Lesion or condition if considered a significant risk factor for major bleeding e.g., current or recent gastrointestinal ulceration, presence of malignant neoplasms at high risk of bleeding, recent brain or spinal injury, recent brain, spinal or ophthalmic surgery, recent intracranial haemorrhage, known or suspected oesophageal varices, arteriovenous malformations, vascular aneurysms or major intraspinal or intracerebral vascular abnormalities. • Concomitant systemic treatment with HIV protease inhibitors, e.g., ritonavir.
- Premature discontinuation of any oral anticoagulant, including Apixaban, increases the risk of thrombotic events. To reduce this risk, consider coverage with another anticoagulant if Apixaban is discontinued for a reason other than pathological bleeding or completion of a course of therapy.
- Epidural or spinal hematomas may occur in patients treated with Apixaban who are receiving neuraxial anesthesia or undergoing spinal puncture. These hematomas may result in long-term or permanent paralysis. Consider these risks when scheduling patients for spinal procedures.
- Apixaban increases the risk of bleeding and can cause serious, potentially fatal, bleeding. Advise patients of signs and symptoms of blood loss and to report them immediately or go to an emergency room. Discontinue Apixaban in patients with active pathological hemorrhage .
- The safety and efficacy of Apixaban have not been studied in patients with prosthetic heart valves. Therefore, use of Apixaban is not recommended in these patients.
Store this medicine at room temperature, away from direct light and heat.
Manufactured by Apixaban Pharmaceuticals (Pvt) Ltd.. Country of origin: Pakistan.
4.5
Rated 4.5 out of 530 verified ratings
- 5★100%
- 4★0%
- 3★0%
- 2★0%
- 1★0%
- Kamran AliVerified Purchase4 Aug 2026Rated 5.0 out of 5
Exactly what my doctor prescribed. The pharmacist called to confirm the strength before dispatch, which I appreciated.
- Bilal Ahmed23 Jul 2026Rated 5.0 out of 5
Exactly what my doctor prescribed. The pharmacist called to confirm the strength before dispatch, which I appreciated.
- Mehwish A.15 Jul 2026Rated 5.0 out of 5
Good value for the pack size. I compared prices across three sites before ordering.
- Fatima S.Verified Purchase5 Jul 2026Rated 5.0 out of 5
Second time ordering. Batch and expiry were printed clearly and matched what the site listed.
Reviews are from verified Hope Pharmacy orders. We do not remove a review for being critical.
What it is used for: Stroke.
Indications as listed by the manufacturer: Apixaban is indicated for: • The prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective knee or hip replacement surgery. • The prevention of stroke and systemic embolism in patients with atrial fibrillation. • The treatment of venous thromboembolic events (deep vein thrombosis [DVT], pulmonary embolism [PE]) and prevention of recurrent DVT and PE.
Active ingredient: Apixaban.
Reported side effects: Common: Haemorrhage, haematoma, epistaxis, gastrointestinal haemorrhage, rectal haemorrhage, gingival bleeding, haematuria and contusion. Uncommon: Pruritus, eye haemorrhage (including conjunctival haemorrhage), haemoptysis, haematochezia, abnormal vaginal haemorrhage, urogenital haemorrhage, occult blood positive, traumatic haemorrhage, post procedural haemorrhage and incision site haemorrhage. Rare: Brain haemorrhage and respiratory tract haemorrhage .
Known drug interactions: Inhibitors of CYP3A4 and P-gp , g. Inducers of CYP3A4 and P-gp (e.g., rifampin, carbamazepine, phenytoin, St. John’s wort) , thrombolytic agents, fibrinolytics, GPIIb/IIIa receptor antagonists, thienopyridines (e.g., clopidogrel), dipyridamole, dextran, heparin, aspirin, chronic NSAID and sulfinpyrazone.
- Sourced through authorised distributors and checked against batch and expiry on arrival
- Dispensed by a registered pharmacist from our DRAP-licensed branches
- Prescription verified by a pharmacist before your order is dispatched
- Same-day delivery in Karachi, Lahore and Islamabad on orders placed before 6pm
Prevention of stroke and systemic embolism in patients with atrial fibrillation : The recommended dose of Apixaban for most patients is 5mg taken orally twice daily. The recommended dose of Apixaban is 2.5mg twice daily in patients with at least two of the following characteristics: • age greater than or equal to 80 years • body weight less than or equal to 60 kg • serum creatinine greater than or equal to 1.5mg/dL . Prevention of venous thromboembolic events (VTE) following Hip or Knee Replacement Surgery : The recommended dose of Apixaban is 2.5mg taken orally twice daily . Treatment of DVT and PE and Prevention of recurrent DVT and PE : The recommended dose of Apixaban is 10mg taken orally twice daily for 7 days, followed by 5mg taken orally twice daily for the treatment of acute DVT or PE . OR As directed by your physician .
Active ingredient: Apixaban. Labelled strength: 2.5mg.
- Apixaban is contraindicated in: • Hypersensitivity to the active substance or to any of the excipient of the product. • Active clinically significant bleeding including GI bleeding. • Hepatic disease associated with coagulopathy and clinically relevant bleeding risk. • Lesion or condition if considered a significant risk factor for major bleeding e.g., current or recent gastrointestinal ulceration, presence of malignant neoplasms at high risk of bleeding, recent brain or spinal injury, recent brain, spinal or ophthalmic surgery, recent intracranial haemorrhage, known or suspected oesophageal varices, arteriovenous malformations, vascular aneurysms or major intraspinal or intracerebral vascular abnormalities. • Concomitant systemic treatment with HIV protease inhibitors, e.g., ritonavir.
- Premature discontinuation of any oral anticoagulant, including Apixaban, increases the risk of thrombotic events. To reduce this risk, consider coverage with another anticoagulant if Apixaban is discontinued for a reason other than pathological bleeding or completion of a course of therapy.
- Epidural or spinal hematomas may occur in patients treated with Apixaban who are receiving neuraxial anesthesia or undergoing spinal puncture. These hematomas may result in long-term or permanent paralysis. Consider these risks when scheduling patients for spinal procedures.
- Apixaban increases the risk of bleeding and can cause serious, potentially fatal, bleeding. Advise patients of signs and symptoms of blood loss and to report them immediately or go to an emergency room. Discontinue Apixaban in patients with active pathological hemorrhage .
- The safety and efficacy of Apixaban have not been studied in patients with prosthetic heart valves. Therefore, use of Apixaban is not recommended in these patients.
Store this medicine at room temperature, away from direct light and heat.
Manufactured by Apixaban Pharmaceuticals (Pvt) Ltd.. Country of origin: Pakistan.
4.5
Rated 4.5 out of 530 verified ratings
- 5★100%
- 4★0%
- 3★0%
- 2★0%
- 1★0%
- Kamran AliVerified Purchase4 Aug 2026Rated 5.0 out of 5
Exactly what my doctor prescribed. The pharmacist called to confirm the strength before dispatch, which I appreciated.
- Bilal Ahmed23 Jul 2026Rated 5.0 out of 5
Exactly what my doctor prescribed. The pharmacist called to confirm the strength before dispatch, which I appreciated.
- Mehwish A.15 Jul 2026Rated 5.0 out of 5
Good value for the pack size. I compared prices across three sites before ordering.
- Fatima S.Verified Purchase5 Jul 2026Rated 5.0 out of 5
Second time ordering. Batch and expiry were printed clearly and matched what the site listed.
Reviews are from verified Hope Pharmacy orders. We do not remove a review for being critical.
Frequently bought together
GSKApixaban 2 5mg Tab 30sRs. 2,155Rated 4.5 out of 5
StandpharmXiga 5mg Tablets 14sRs. 1,595Rated 4.5 out of 5
Martin DowAldactone Tablets 100mg 10sRs. 1,390Rated 4.5 out of 5
Bundle total
Rs. 5,140Rs. 5,500
Information on this site is for general guidance and is not a substitute for professional medical advice. Always consult your doctor or pharmacist.
You might also like
More in Medicine
